A DISCUSSION OF
STEM CELL TRANSPLANTATION INTO THE FRONTAL MOTOR CORTEX IN ALS PATIENTS
TECNOLOGICO DE MONTERREY SCHOOL OF MEDICINE, MONTERREY, MEXICO
The autologous stem cell procedure, instituted specifically for ALS and developed by Tecnologico de Monterrey, the internationally acclaimed health sciences, education and biotechnology institution, is presented here. Please take this opportunity to examine, in depth, the many and varied aspects of this procedure. The following topics are included in this discussion.
- Background Information of the Stem Cell Transplantation for ALS Patients
- Primary Physician Co-Authors of the Clinical Test Study
- Description of the Procedure
- Safety of the Procedure
- Justification for Usage of CD133(+) Stem Cells
- Duration of Hospitalization
- Funding of Research
- Extra Expenses for those seeking this treatment
- Standard Tests Performed
- Anticipated Results from the Procedure
- Description and Standards of Hospital
- Measurement of Pre- and Post-Procedure Results
- Further Stem Cell Procedure(s)
- Major Protocol Modifications Following Phase I and II Clinical Test Studies
- The City and Tecnologico de Monterrey
- Research Subject Scheduling
- Additional Information
Please go to Discussion of Stem Cell Transplantation for the complete discussion.
The first two international ALS research subjects, both from the US, traveled to Hospital San Jose Tecnologico (photo shown) in Monterrey, Mexico in early June to participate in this study. In the past six months, more than twenty additional research subjects have received the protocol. The first will return to Monterrey for the follow-up cranial MRI tractography during the month of December 2009 and we are looking forward to seeing the results soon.
Hospital San Jose Tecnologico de Monterrey
|
